Delisting risk
APM · NASDAQ · Biotechnology

Aptorum Group (APM)

Developing oncology, infectious disease, and diagnostic assets for unmet medical needs.

$8.26
At close−1.44 (−14.84%)

Something off on this page? Send us feedback.

EPSReportedEstimate

Sep '23Dec '23Apr '24Dec '24Apr '25Apr '25Oct '25Apr '26
Reported−$22.20−$14.30$5.10−$5.00−$0.29−$2.90−$0.62−$1.30
Estimate−$26.00−$26.00−$27.00−$26.00−$2.70
Surprise+14.6%+45.0%+118.9%+80.8%−7.4%

RevenueReportedEstimate

Sep '23Dec '23Apr '24Dec '24Apr '25Apr '25Oct '25Apr '26
Reported$768.4K$431.4K
Estimate$800.0K$1.0M$1.3M$1.0M$1.3M
Surprise−3.9%−56.9%

History

DateEstimateReportedSurprise
Jul 2026
Jun 2026
Apr 2026−$1.30
Jan 2026
Oct 2025−$0.62
Apr 2025−$2.70−$2.90−7.4%
Apr 2025−$0.29

The latest year is open to everyone — the 15 quarters behind it read with an account.

Sign in
Dec 2024
Apr 2024
Dec 2023
Sep 2023
Apr 2023
Sep 2022
Apr 2022
Dec 2021
Sep 2021
Apr 2021
Sep 2020
Apr 2020
Sep 2019
Apr 2019
Dec 2018
Report dateEPS estEPSSurpriseRevenue estRevenueSurpriseReaction
Jul 3, 2026
Jun 26, 2026
Apr 28, 2026−$1.30+1.5%
Jan 22, 2026
Oct 3, 2025−$0.62+3.1%
Apr 30, 2025−$2.70−$2.90−7.4%$1.3M−2.0%
Apr 28, 2025−$0.29−2.0%

The latest year is open to everyone — the 15 quarters behind it read with an account.

Sign in
Dec 20, 2024
Apr 30, 2024
Dec 22, 2023
Sep 30, 2023
Apr 28, 2023
Sep 30, 2022
Apr 29, 2022
Dec 3, 2021
Sep 15, 2021
Apr 19, 2021
Sep 1, 2020
Apr 29, 2020
Sep 9, 2019
Apr 15, 2019
Dec 4, 2018